Ascendis Pharma's total assets for Q4 2025 were €1.30B, an increase of 12.75% from the previous quarter. ASND total liabilities were €1.46B for the fiscal quarter, a 10.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.